T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
T. Rowe Price Growth Stock ETF
TGRW
$977M
| $133M | 0.02% |
3,295,001
+925,000
| +39% | +$40.3M |
|
552
Alamos Gold
AGI
$12.4B
| $133M | 0.02% |
3,002,652
-71,245
| -2% | -$3.14M |
|
553
West Pharmaceutical
WST
$23.1B
| $132M | 0.02% |
526,383
+187,116
| +55% | +$46.6M |
|
554
Molina Healthcare
MOH
$10.3B
| $131M | 0.02% |
981,749
-12,511
| -1% | -$1.99M |
|
555
Zurn Elkay Water Solutions
ZWS
$8.07B
| $131M | 0.02% |
2,916,087
+167,397
| +6% | +$8M |
|
556
PNC Financial Services
PNC
$100B
| $131M | 0.02% |
627,208
-108,177
| -15% | -$23.6M |
|
557
NOV
NOV
$7.45B
| $130M | 0.02% |
6,921,865
+1,862,465
| +37% | +$35M |
|
558
Credo Technology Group
CRDO
$39.7B
| $130M | 0.02% |
1,386,740
-2,424,856
| -64% | -$295M |
|
559
Shoals Technologies Group
SHLS
$1.58B
| $129M | 0.01% |
19,595,190
+6,841,406
| +54% | +$56.1M |
|
560
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.75B
| $129M | 0.01% |
+1,725,000
| New | +$122M |
|
561
Darden Restaurants
DRI
$22.5B
| $129M | 0.01% |
656,760
+18,003
| +3% | +$3.7M |
|
562
Bio-Techne
TECH
$11.2B
| $128M | 0.01% |
2,447,331
-1,627,863
| -40% | -$97.7M |
|
563
Dycom Industries
DY
$12.9B
| $127M | 0.01% |
374,054
-184,465
| -33% | -$69.3M |
|
564
IQVIA
IQV
$34.7B
| $127M | 0.01% |
741,900
+45,324
| +7% | +$8.84M |
|
565
TC Energy
TRP
$73.5B
| $126M | 0.01% |
2,018,598
-412,394
| -17% | -$24.9M |
|
566
Life Time Group Holdings
LTH
$9.42B
| $126M | 0.01% |
4,670,211
+1,890,952
| +68% | +$52.3M |
|
567
General Dynamics
GD
$105B
| $125M | 0.01% |
365,546
-6,559
| -2% | -$2.33M |
|
568
e.l.f. Beauty
ELF
$4.56B
| $125M | 0.01% |
2,067,396
-129,923
| -6% | -$10.6M |
|
569
Krystal Biotech
KRYS
$9.88B
| $125M | 0.01% |
485,074
-44,881
| -8% | -$11.9M |
|
570
BWX Technologies
BWXT
$16B
| $125M | 0.01% |
612,117
+13,822
| +2% | +$2.81M |
|
571
Kanzhun
BZ
$6.89B
| $125M | 0.01% |
9,304,408
-112,351
| -1% | -$1.9M |
|
572
Onto Innovation
ONTO
$13.6B
| $124M | 0.01% |
605,783
-74,483
| -11% | -$15.2M |
|
573
Acuity Brands
AYI
$9.88B
| $124M | 0.01% |
441,530
+21,173
| +5% | +$6.43M |
|
574
Cogent Biosciences
COGT
$6.79B
| $124M | 0.01% |
3,212,815
+648,753
| +25% | +$24M |
|
575
Biogen
BIIB
$29.9B
| $123M | 0.01% |
672,427
-119,644
| -15% | -$22M |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.